美国和印度发起了一个联合禁毒政策小组,通过加强合作打击贩运、合成毒品和毒品恐怖主义。 U.S. and India launched a joint drug policy group to combat trafficking, synthetic drugs, and narco-terrorism through enhanced cooperation.

美国和印度发起了美国-印度药物政策执行工作组,于2026年1月20日至21日在哥伦比亚特区华盛顿举行了首次会议,由美国和印度官员共同主持。 The U.S. and India launched the US-India Drug Policy Executive Working Group with its first meeting in Washington, D.C., from January 20–21, 2026, co-chaired by U.S. and Indian officials. 该小组旨在加强打击贩毒和毒品恐怖主义的双边努力,针对非法生产和前体化学品,加强机构间协调,确保药品供应链安全。 The group aims to strengthen bilateral efforts against drug trafficking and narco-terrorism by targeting illicit production and precursor chemicals, enhancing interagency coordination, and securing pharmaceutical supply chains. 两国都强调合成药物和跨界网络的威胁日益增大,重申在支持合法贸易的同时,采取全政府办法应对这些挑战。 Both nations emphasized the growing threat of synthetic drugs and cross-border networks, reaffirming a whole-of-government approach to combat these challenges while supporting legitimate trade. 该倡议标志着它们安全与执法合作的重大扩展。 The initiative marks a significant expansion of their security and law enforcement cooperation.